Investigation the effect of probiotics in patients with COVID-19

Early Phase 1

Recruiting

• Conditions: COVID-19.; COVID-19

• Registration Number: IRCT20220124053820N1
• Lead Sponsor: Research deputy of Rasht Islamic Azad University and Zist Takhmir company

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients who are hospitalization due to COVID-19. Patients should be 18 years old and older. Patients should have clinical symptoms and pneumonia of covid in chest radiography or CT scan. Patients should not particitaion in other clinical trials at the same time.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eed to admission to ICU. Timepoint: Daily. Method of measurement: By evaluator using patient's file and ward's information.;Need to intubation. Timepoint: Daily. Method of measurement: By evaluator using patient's file and ward's information.;Mortality. Timepoint: Daily. Method of measurement: By evaluator using patient's file and ward's information.;Vital signs. Timepoint: Three times a day. Method of measurement: By evaluator using mercury sphygmomanometer and t?ermometer.;Symptoms consisting cough, dyspnea, diarrhea, abdominal pain. Timepoint: Daily. Method of measurement: By evaluator asking patient and patient's file.;O2 saturation. Timepoint: Three times a day. Method of measurement: By evaluator using pulse oxymeter.;Laboratories tests: Hb, Platelet, ESR, CRP, WBC, lymphocyce, NLR, CPK, ALT, AST, fibrinogen, D-dimer. Timepoint: Daily. Method of measurement: By Razi Hospital Laboratory.;Length of hospitalization. Timepoint: Daily. Method of measurement: By evaluator by pstient's file.